Literature DB >> 15809089

Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector.

Narayanasamy Elango1, Suratha Elango, Pooja Shivshankar, Michael S Katz.   

Abstract

Studies employing mRNA transfection are currently limited by a lack of transcription vectors for generating a long poly(A) tail-containing mRNA and published methods for efficient mRNA transfection. We have constructed a transcription vector containing firefly luciferase gene (pBS-FLuc-A100) to generate luciferase mRNA with A100 tail followed by no heterologous sequence. The pBS-FLuc-A100 was propagated in XL1-Blue, in which the plasmid was more stable than in other bacterial strains. Optimal mRNA transfection conditions were determined using TransMessenger Transfection Reagent (Qiagen) and yeast tRNA as a carrier. Firefly luciferase expression, which peaked at about 12 h post-transfection, was detected with as little as 5 ng mRNA and was linear with mRNA amount up to 100 ng. When cells were transfected with luciferase mRNA containing different lengths of poly(A) tail, luciferase expression increased proportionally with poly(A) tail length up to 60A residues and then declined. Cell lines from monkey, mouse, and rat were transfected efficiently by this method. Like cellular ferritin heavy chain mRNA, which contains an iron response element in its 5'UTR, translation of transfected luciferase mRNA containing the 5'UTR of ferritin mRNA was iron-dependent. Our results demonstrate that the poly(A) vector and the transcription method described will be useful to study the regulation of gene expression at the mRNA level by UTRs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809089     DOI: 10.1016/j.bbrc.2005.03.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.

Authors:  Sanders Oh; John A Kessler
Journal:  Methods       Date:  2017-11-07       Impact factor: 3.608

Review 2.  Developing mRNA-vaccine technologies.

Authors:  Thomas Schlake; Andreas Thess; Mariola Fotin-Mleczek; Karl-Josef Kallen
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

3.  Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs.

Authors:  Sang-Mi Kim; Mi-Sun Lim; Eun-Hye Lee; Sung Jun Jung; Hee Yong Chung; Chun-Hyung Kim; Chang-Hwan Park
Journal:  Mol Ther       Date:  2017-07-11       Impact factor: 11.454

4.  A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.

Authors:  Yoonsu Choi; Carrie Yuen; Sourindra N Maiti; Simon Olivares; Hillary Gibbons; Helen Huls; Robert Raphael; Thomas C Killian; Daniel J Stark; Dean A Lee; Hiroki Torikai; Daniel Monticello; Susan S Kelly; Partow Kebriaei; Richard E Champlin; Sibani L Biswal; Laurence J N Cooper
Journal:  Biomed Microdevices       Date:  2010-10       Impact factor: 2.838

Review 5.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

6.  A Simple, Highly Efficient Method for Heterologous Expression in Mammalian Primary Neurons Using Cationic Lipid-mediated mRNA Transfection.

Authors:  Damian J Williams; Henry L Puhl; Stephen R Ikeda
Journal:  Front Neurosci       Date:  2010-11-04       Impact factor: 4.677

Review 7.  The Past, Present, and Future of Non-Viral CAR T Cells.

Authors:  Alex Moretti; Marianna Ponzo; Charles A Nicolette; Irina Y Tcherepanova; Andrea Biondi; Chiara F Magnani
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 8.  mRNA-Based Genetic Reprogramming.

Authors:  Luigi Warren; Cory Lin
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

9.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

Review 10.  Mammalian cell transfection: the present and the future.

Authors:  Tae Kyung Kim; James H Eberwine
Journal:  Anal Bioanal Chem       Date:  2010-06-13       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.